Medicare can cover gynecomastia surgery, but only when the procedure is classified as reconstructive rather than cosmetic. The key distinction comes down to medical necessity: if enlarged breast tissue causes documented pain, functional problems, or meets a specific severity grade, Medicare considers the surgery a covered benefit. Purely aesthetic chest contouring is explicitly excluded.
When Medicare Considers It Medically Necessary
Medicare uses a grading scale developed by the American Society of Plastic Surgeons to determine severity. Grade III gynecomastia involves moderate breast enlargement that extends beyond the areola with visible skin redundancy. Grade IV is marked enlargement with significant skin redundancy and feminization of the breast. If your gynecomastia falls into either of these categories, Medicare classifies surgical correction as reconstructive and medically reasonable.
Beyond the grading scale, Medicare also covers surgery when gynecomastia causes pain or tenderness that significantly affects your daily activities, when excessive breast weight is straining your shoulders, neck, or back, or when you have abnormal breast development with redundant tissue. You don’t necessarily need to meet the Grade III or IV threshold if your symptoms are well documented and severe enough to interfere with normal functioning.
There are timing requirements too. The gynecomastia must persist for more than three to four months after pathological causes have been ruled out. If an underlying condition is identified and treated, the breast tissue still needs to remain for three to four months after unsuccessful medical treatment before surgery qualifies. Medicare also expects that pain-related symptoms have not responded to a trial of pain relievers or anti-inflammatory medications.
What Medicare Won’t Cover
Federal regulations exclude cosmetic surgery from Medicare coverage except when it repairs accidental injury or improves the function of a malformed body part. Surgery performed solely to improve the appearance of the male chest or alter chest wall contours falls squarely into the cosmetic category and will be denied.
Using surgery as a first-line treatment, before conservative approaches have been tried, is also excluded. Medicare expects a documented progression from diagnosis through medical management before approving a surgical claim. Liposuction performed alongside the primary procedure is considered part of the surgery and won’t be reimbursed as a separate service.
Documentation Your Doctor Needs to Provide
Getting a claim approved requires specific medical evidence in your file. Your doctor will need to confirm true gynecomastia (glandular breast tissue, not just fat) through physical examination and often mammography. A mammogram report is expected for age-appropriate patients, and a pathology report from the removed tissue will be required after surgery.
Before surgery is authorized, hormonal causes need to be excluded through lab work. This typically means blood tests checking thyroid function, estrogen levels, prolactin, testosterone, and luteinizing hormone. The purpose is to rule out conditions like hyperthyroidism, estrogen excess, or low testosterone that might resolve the gynecomastia without surgery. If one of these conditions is found, it needs to be treated first, and the gynecomastia must persist despite that treatment.
Original Medicare vs. Medicare Advantage
Under Original Medicare (Parts A and B), gynecomastia surgery performed in an outpatient setting is generally billed under Part B. Coverage decisions are guided by Local Coverage Determinations, which are regional policies that can vary somewhat depending on where you live. There is no single national policy for gynecomastia, so the specific criteria your Medicare contractor applies may differ slightly from another region’s.
Medicare Advantage plans (Part C) must cover everything Original Medicare covers, but they can layer on additional requirements. Some plans require prior authorization before the procedure, and the specifics depend on the insurer managing your plan. UnitedHealthcare’s Medicare Advantage policies, for example, direct providers to follow applicable Local Coverage Determinations where they exist, and fall back on commercial guidelines where they don’t. If you’re on a Medicare Advantage plan, contacting your insurer before scheduling surgery is essential to confirm what documentation and approvals are needed.
What You’ll Pay Out of Pocket
Even when Medicare covers the surgery, you’re responsible for cost-sharing. In 2026, the Part B deductible is $283 per year. After meeting that deductible, you typically pay 20% of the Medicare-approved amount for doctor and provider services. For procedures done in a hospital outpatient setting, you’ll also owe a copayment to the hospital for each service, though in most cases that copayment won’t exceed the Part A inpatient deductible amount.
If you have a Medigap (supplemental) policy, it may cover some or all of that 20% coinsurance. Medicare Advantage plans set their own copayment and coinsurance structures, so your share could be higher or lower depending on the plan. Either way, the total out-of-pocket cost for a covered gynecomastia surgery through Medicare will be substantially less than paying for the procedure entirely on your own, which can run several thousand dollars.
How to Improve Your Chances of Approval
The most common reason claims are denied is insufficient documentation. Before pursuing surgery, make sure your medical record includes a clear physical exam confirming glandular tissue, imaging results, lab work ruling out hormonal causes, and notes showing that conservative treatment was attempted and failed over an adequate period. Photographs documenting the severity can also support the case for Grade III or IV classification.
Your surgeon should be familiar with Medicare’s coverage criteria and comfortable coding the procedure as reconstructive rather than cosmetic. If a claim is denied, you have the right to appeal. Denials sometimes result from missing paperwork rather than a true coverage exclusion, and resubmitting with complete documentation can reverse the decision.